Healthcare -
Biotechnology - NYSE - US
$ 10.52
-3.4 %
$ 1.11 B
Market Cap
-3.35
P/E
RCUS - STOCK-BASED COMPENSATION
Stock-based Compensation RCUS - Arcus Biosciences, Inc.
73 M
LAST VALUE
15.21%
2 YEAR CAGR
79.90%
5 YEAR CAGR
0.00%
10 YEAR CAGR